Nuvasive Inc. (NUVA) 57.95 $NUVA What Investors are

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2016 at 2:07 PM

Nuvasive Inc. (NUVA) 57.95 $NUVA

What Investors are Making of These Healthcare Stocks? - Antares Pharma, Globus Medical, NuVasive, and Insulet
PR Newswire - Fri Jun 24, 6:49AM CDT
Since the financial crisis, the Healthcare sector has proven to be defensive against market downturns, continuing to present opportunities for growth. Today's featured companies on Stock-Callers.com belong in this arena: Antares Pharma Inc. (NASDAQ: ATRS), Globus Medical Inc. (NYSE: GMED), NuVasive Inc. (NASDAQ: NUVA), and Insulet Corp. (NASDAQ: PODD). Learn more about these stocks and receive your complimentary trade alerts at:
PODD: 28.77 (-0.68), GMED: 23.59 (-0.32), NUVA: 57.95 (-0.91), ATRS: 0.97 (-0.04)

Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:26AM CDT
On Jun 22, 2016, we issued an updated research report on Walgreens Boots Alliance, Inc. (WBA).
WBA: 82.09 (-2.97), LMAT: 14.46 (-0.36), STJ: 77.22 (-1.27), NUVA: 57.95 (-0.91)

Hill-Rom Introduces VisiVest, First Connected Airways System
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
Hill-Rom Holdings, Inc. (HRC) recently launched VisiVest System, the world's first wirelessly connected airway clearance system.
ICUI: 106.03 (-2.10), LMAT: 14.46 (-0.36), NUVA: 57.95 (-0.91), HRC: 50.40 (-1.66)

Shares of NUVA Up 33.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 17, 12:44AM CDT
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on March 4th, 2016 at $43.48. In approximately 3 months, NuVasive has returned 33.16% as of today's recent price of $57.90.
NUVA: 57.95 (-0.91)

Qiagen???s QIAsure Test to Determine Cervical Cancer Risks
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:33AM CDT
Qiagen's (QGEN) QIAsure accurately stratifies cervical cancer risk, which offers highly sensitive and specific results for patients and clinicians.
BAX: 44.01 (-1.95), LMAT: 14.46 (-0.36), QGEN: 21.07 (-1.32), NUVA: 57.95 (-0.91)

Boston Scientific: NICE Backs GreenLight XPS for BPH Cure
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:01AM CDT
As per NICE's estimates, broad adoption of Boston Scientific's (BSX) GreenLight therapy over TURP can lead to savings of up to ??3.2 million annually for the National Health Service (NHS).
BSX: 22.55 (-0.42), BAX: 44.01 (-1.95), LMAT: 14.46 (-0.36), NUVA: 57.95 (-0.91)

Bruker Well Poised on Product Innovation amid Currency Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:23AM CDT
On Jun 14, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
ICUI: 106.03 (-2.10), LMAT: 14.46 (-0.36), BRKR: 23.08 (-1.32), NUVA: 57.95 (-0.91)

PetMed Remains Strong on New Order & Reorder Sales Gain
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 10:15AM CDT
On Jun 13, 2016, we issued an updated research report on PetMed Express (PETS).
ICUI: 106.03 (-2.10), PETS: 18.39 (-0.11), LMAT: 14.46 (-0.36), NUVA: 57.95 (-0.91)

Why NuVasive (NUVA) Could Beat Earnings Estimates Again
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 8:25AM CDT
Positive Earnings ESP coupled with an impressive Zacks Rank has made NuVasive (NUVA) an interesting choice for the investors.
NUVA: 57.95 (-0.91)

NuVasive Shares Up 37.0% Since SmarTrend's Buy Recommendation (NUVA)
Comtex SmarTrend(R) - Thu Jun 09, 1:14PM CDT
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on March 4th, 2016 at $43.48. In approximately 3 months, NuVasive has returned 37.01% as of today's recent price of $59.57.
NUVA: 57.95 (-0.91)

NuVasive to Strengthen Spine Service Line with Biotronic Buy
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:17AM CDT
NuVasive, Inc. (NUVA) recently entered into a definitive agreement to acquire privately held Biotronic NeuroNetwork.
BSX: 22.55 (-0.42), ICUI: 106.03 (-2.10), BAX: 44.01 (-1.95), NUVA: 57.95 (-0.91)

NuVasive to Acquire Biotronic NeuroNetwork
Marketwired - Mon Jun 06, 3:05PM CDT
SAN DIEGO, CA--(Marketwired - June 06, 2016) -
NUVA: 57.95 (-0.91)

Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 106.03 (-2.10), ABAX: 44.82 (-2.29), LMAT: 14.46 (-0.36), NUVA: 57.95 (-0.91)

Moving Average Crossover Alert: NuVasive (NUVA)
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 9:55AM CDT
NuVasive, Inc. (NUVA) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
NUVA: 57.95 (-0.91)

NuVasive Has Returned 28.3% Since SmarTrend Recommendation (NUVA)
Comtex SmarTrend(R) - Thu Jun 02, 1:01AM CDT
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on March 4th, 2016 at $43.48. In approximately 3 months, NuVasive has returned 28.29% as of today's recent price of $55.78.
NUVA: 57.95 (-0.91)

NuVasive Poised on Solid International Sales, Scope in Spine
Zacks Equity Research - Zacks Investment Research - Tue May 31, 6:01AM CDT
On May 30, 2016, we updated our research report on NuVasive, Inc. (NUVA).
BSX: 22.55 (-0.42), ICUI: 106.03 (-2.10), LMAT: 14.46 (-0.36), NUVA: 57.95 (-0.91)

NuVasive to Participate in Investor Events in June 2016
Marketwired - Tue May 31, 6:00AM CDT
SAN DIEGO, CA --(Marketwired - May 31, 2016) - NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that management will participate in the following investor events in June 2016:
NUVA: 57.95 (-0.91)

After Yesterday's Rally of 2.61% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri May 27, 2:10PM CDT
NuVasive (NASDAQ:NUVA) traded in a range yesterday that spanned from a low of $53.25 to a high of $55.21. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $54.31 on volume of 320,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NUVA: 57.95 (-0.91)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HelloNation Brings 'Edvertising' to NC REALTORS® Event

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

C3EL Expands Federal Footprint with Strategic Contracts

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Merit Expands in New York with Bold Acquisition Move

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Ornellaia's 2026 Harvest: Adapting to Nature's Whims

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Decoding CarBravo-Certified vs Traditional Used Cars

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

EMCO's New Automated Facility Could Shake Industry

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Duke Energy's Cost-Protection Plan Shields Ratepayers

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Wally Disrupts Dental Industry with $25M Funding

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...